Muscular
Muscular capability focuses on prevention, diagnosis, repair and functional restoration of skeletal muscle in combat and austere settings. It spans acute trauma management, mitigation of disuse atrophy, regenerative therapies, biomaterial scaffolds, imaging and rehabilitation technologies to sustain Warfighter readiness and recovery.
Technical Challenges
Polytrauma and blast-induced muscle loss with heterogeneous wounds and contamination complicate predictable repair.
Limited point-of-care diagnostics to assess muscle viability and perfusion in austere or prolonged-field-care scenarios.
Infection risk, biofilm formation, and antimicrobial resistance (AMR) impair grafts, implants, and healing.
Fibrosis, chronic inflammation, and impaired reinnervation leading to long-term functional deficits.
Translational gaps: scalable, shelf-stable regenerative therapies that are deployable and logistically feasible are lacking.
Emerging Opportunities
Portable, rapid assays and imaging to determine muscle viability and guide debridement or reconstruction.
Field-compatible regenerative or biologic products that do not require cold chain or complex delivery.
Therapies that prevent or reverse fibrosis and accelerate reinnervation in polytrauma patients.
Validated wearable biomarkers and decision-support tools to monitor recovery and readiness in distributed care.
Integrated rehabilitation platforms (neuromodulation + robotics) optimized for austere settings and constrained resources.
Current and Emerging Technologies in Muscular
Regenerative biologics & cell therapies
Mesenchymal and muscle progenitor cell therapies, allogeneic cell banks, exosomes and growth-factor formulations to accelerate myogenesis and tissue repair.
Biomaterials and bioengineered scaffolds
Resorbable scaffolds, aligned fiber matrices, and injectable hydrogels that support vascularization, reduce fibrosis, and guide muscle regeneration.
Point-of-care diagnostics & imaging
Portable ultrasound, elastography, near-infrared spectroscopy, and biomarker assays for real-time assessment of perfusion, viability and inflammation.
Neuromodulation and wearable rehabilitation
Transcutaneous electrical stimulation, implantable neurostimulation, and wearable exosuits to prevent atrophy, retrain motor patterns, and augment force generation.
Advanced therapeutics: gene & molecular approaches
Localized gene delivery, RNA therapeutics, and targeted antifibrotic molecules to modify regenerative pathways and limit scarring.
Rehabilitation robotics and tele-rehab
Portable robotic devices, task-specific training platforms and telehealth-integrated monitoring that extend rehabilitation into remote or prolonged-care environments.
Importance to Military Medicine
Combat casualty care and functional survival
Effective muscle preservation and repair reduce disability after blast and penetrating trauma, enabling earlier return to duty or transition to definitive care.
Prolonged and delayed evacuation scenarios
Field-deployable diagnostics and interventions mitigate atrophy and infection risk when evacuation is delayed or care is delivered in austere settings.
Force readiness and rehabilitation
Rapid, effective rehabilitation reduces long-term disability, shortens recovery timelines, and preserves unit readiness and personnel availability.
Austere environments and dual-use impact
Solutions optimized for low-resource and forward settings translate directly to civilian trauma care, disaster response and rural health systems.
Alignment with the MTEC Mission
Accelerates translation of muscle-focused therapeutics and devices from prototype to field-ready products aligned with DoD priorities for survivability and readiness.
Supports multidisciplinary integration across combat casualty care, regenerative medicine, neurorehabilitation and prolonged field care—core portfolio areas for MTEC.
Emphasizes dual-use impact—advancing technologies that benefit Warfighters while delivering civilian health gains in trauma and chronic muscle disorders.
Enables rapid, consortium-based projects that leverage MTEC funding models, clinical networks, and DoD testing infrastructure to de-risk and accelerate adoption.
Dual-Use (Military + Civilian) Applications
Civilian trauma centers and emergency medicine benefit from improved wound management, infection control and rapid diagnostics developed for forward settings.
Chronic muscle disease and geriatric care gain from regenerative approaches, antifibrotic therapies and tele-rehab platforms originally designed for Warfighter recovery.
Sports medicine, orthopedics and occupational health adopt wearables, neuromodulation and robotic rehabilitation to accelerate functional outcomes.
Telehealth-enabled monitoring and decision-support developed for distributed military care support disaster response and remote civilian healthcare delivery.
Explore MTEC Members with Muscular Capabilities
MTEC members bring multidisciplinary expertise—biomaterials, cell therapy, medical devices, imaging and rehabilitation—enabling integrated solutions from bench to bedside.
Members leverage DoD-aligned clinical networks, preclinical testing facilities and regulatory experience to de-risk products for rapid field evaluation and adoption.
Industry partners provide scalable manufacturing and logistics solutions for deployable biologics and devices; academia contributes mechanistic science and rigorous evaluation.
Explore member profiles to identify collaborators with strengths in regenerative platforms, point-of-care diagnostics, neuromodulation, robotics and field-deployable manufacturing.
81 Members with Muscular capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.
Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.
STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.
The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
The Institute for Integrative & Innovative Research (I³R) at the University of Arkansas is dedicated to pioneering solutions to wicked problems and societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I³R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.
UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.
Action Medical Technologies is a pharmaceutical and medical device company focused on developing innovative solutions that integrate medications with advanced devices and injector systems to improve patient outcomes, particularly in austere prehospital environments.
Revolution Biomanufacturing Inc. (RBIx) is expanding beyond traditional CDMO Process/Analytical Development and Manufacturing services to pioneer distributed molecular manufacturing. A new class of digital biomanufacturing that enables the autonomous design, manufacture, quality verification, and deployment of Nucleic Acid therapeutics and molecular diagnostics at the point of need. By integrating AI-driven sequence optimization, enzymatic nucleic acid synthesis, Nanoparticle design and manufacturing (LNP & EV), closed-loop quality control, and field-deployable manufacturing platforms, RBIx is creating adaptive biological infrastructure capable of responding to emerging diseases, national security threats, and personalized medicine with unprecedented speed and flexibility.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.
Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.
Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.
Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.
Purgo Scientific is a medical device company dedicated to developing effective solutions for the biofilm infections crisis in orthopedic surgery. Their mission is to provide a locally targeted sustained delivery device that ensures the right therapy is delivered to the right place for the right duration, ultimately improving patient outcomes and reducing the impact of surgical site infections.
Limax Biosciences is dedicated to revolutionizing tissue healing through innovative biomaterials inspired by the natural slime of slugs. Their hydrogels provide superior adhesion and healing capabilities, addressing unmet medical needs both inside and outside the body.
The UT Arlington Research Institute (UTARI) specializes in applying cutting-edge technologies to real-world engineering problems. Our collaborative endeavors reflect a commitment to excellence, integrity, and respect for all, bringing economic growth and fulfillment to our families, business partners, university, and community.
Safi Biotherapeutics
Next-Generation Manufactured Red Blood Cells for Extended Battlefield Blood Supply: Safi Biotherapeutics
Safi Biotherapeutics is developing manufactured red blood cells (mRBCs) with extended shelf life to improve battlefield transfusion readiness and emergency trauma care.
Non-Invasive Glymphatic (GF) Monitoring and Recovery Optimization for Warfighter Cognitive Readiness
Applied Cognition is developing non-invasive glymphatic monitoring and recovery technologies to enhance warfighter cognitive readiness, resilience, and sleep recovery.
Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.
University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.